TietoEVRY Corp (0KG0)
London Exchange · UK · prices in EUR · close of 20 Oct 2026
Key indicators
| Last close | EUR 18.79 |
|---|---|
| 52-week range | 15.44 – 21.35 |
| Return, 1 month / 3 months | +2.0% / +8.4% |
| Return, 1 year / 3 years | +20.2% / +14.0% |
| Trend | Uptrend |
| RSI (14) | 56 |
| Volatility (1 year) | 30.9% |
| Worst drawdown (1 year) | -19.5% |
| Average daily value traded | 0.63M EUR |
| Dividend yield | 4.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
TietoEVRY is a Nordic information technology services company that supplies software, digital services and consulting to businesses and public sector organisations. Its work covers cloud services, application development and the modernisation of IT systems, along with industry-specific software for sectors such as banking, healthcare and the public sector. The company is based in Finland and serves customers mainly across the Nordic countries, with additional operations in other parts of Europe and beyond.
TietoEVRY Corp trades under the code 0KG0 on the London Exchange in UK, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
TietoEVRY Corp (0KG0) trades on the London Exchange in UK. It last closed at EUR 18.79 on 20 October 2026.
Its price-based Market X-Ray is 61 out of 100 (a fair price profile), ranking 1,230 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 20.2% and over the last three months it rose 8.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 59 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 2.4% | ||
| From 52-week high | -9.8% | ||
| Momentum | 65 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 8.4% | ||
| 6-month return | 1.7% | ||
| 12-month return, skipping the last month | 17.9% | ||
| Stability (higher is calmer) | 67 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 30.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -19.5% | ||
| Liquidity | 48 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.63M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 63 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 4.7% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +1.1% |
|---|---|
| 1 month | +2.0% |
| 3 months | +8.4% |
| 6 months | +1.7% |
| 1 year | +20.2% |
| 3 years | +14.0% |
| 5 years | −6.7% |
Signals
| 50-day / 200-day average | 18.61 / 18.34 |
|---|---|
| Golden / death cross (60 days) | Golden, 27 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.32 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 22 Sep 2026 | EUR 0.4400 |
| 25 Mar 2026 | EUR 0.4400 |
| 22 Sep 2025 | EUR 0.6700 |
| 26 Mar 2025 | EUR 0.6700 |
| 20 Sep 2024 | EUR 0.7350 |
| 14 Mar 2024 | EUR 0.7350 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.